User Reviews for Acalabrutinib
Also known as: Calquence
|Chronic Lymphocytic Leukemia||1 reviews||23 medications|
|Mantle Cell Lymphoma||1 reviews||9 medications|
Reviews may be moderated or edited before publication to correct grammar and spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest in the medication will not be published. As reviews and ratings are subjective and self-reported, this information should not be used as the basis for any statistical analysis or scientific studies.
For Mantle Cell Lymphoma: “Remission after Retuxen and Bendeka was only about 4-5 months at best so this was next after one failure. 1st month was fine- few side effects and obvious symptoms decreased but by the end of month 3 my symptoms returned. Side effects became distressing- GERD with fatty sensations, nightly abdominal pain … so disappointing. It seems odd for a mere patient to review a drug since medicine is hardly straight forward.”
Calquence (acalabrutinib) for Chronic Lymphocytic Leukemia: “Have had CLL for 10 years. Joined early MDAnderson ACP196 trial for previously untreated 6 years ago, after having great build up of fluid around lungs. All problems went away within a couple of months after starting treatment. Life is normal with no side effects. Have traveled the world since. Still a trial participant.”
This information is NOT intended to endorse any particular medication. While these reviews might be helpful, they are not a substitute for the expertise, knowledge and judgement of healthcare practitioners.
More about acalabrutinib
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Interactions
- En Español
- Drug class: BTK inhibitors
- Other brands